510(k) Report

510(k) · Cleared

Cleared

Bayer Immuno 1 Her-2/Neu Assay

K992228510(k) TraditionalCleared Sep 29, 2000455-day reviewClass II21 CFR 866.6010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bayer Corp. · NCW System, Test, Her-2/Neu, Monitoring

Cleared on Sep 29, 2000 after a 455-day review. The FDA summary names no predicate by number. 1 later device descends from it.

Decided
Sep 29, 2000
Review
455 days
Class
Class II
Product code
NCW
Recalls
None
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2003: 1 descendant cleared200020052010201520202025
  1. This deviceK992228 Bayer Immuno 1 Her-2/Neu AssayBayer Corp. · 2000
  2. Descendant · cites it directly · 0 of its ownK024017 Bayer Advia Centaur Her-2/Neu AssayBayer Corp. · 2003 · Recalled

Most influential descendants

Showing 1 of 1 · See all
  • K024017Bayer Advia Centaur Her-2/Neu AssayBayer Corp. · 2003 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K992228Bayer Immuno 1 Her-2/Neu AssayBayer Corp.2000—
+1K024017Bayer Advia Centaur Her-2/Neu AssayBayer Corp.20031

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
FIG. 1 — Lineage of K992228, 2000–2003Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NCW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K024017Bayer Advia Centaur Her-2/Neu AssayBayer Corp.20030

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K024017 (Bayer Corp., 2003) has gone furthest, with 0 descendants of its own.

How does its category compare?

All NCW devices

NCW System, Test, Her-2/Neu, Monitoring: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NCW

FDA has decided no NCW device since 2007.

Median 510(k) review, days · NCW

Too few NCW 510(k)s in any year since 2007 to give a median.

Recalls per year · NCW

1in 2020

2020: 1
2007high 1 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NCW

No MAUDE report names NCW since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—10
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The Bayer Immuno 1™ Her-2/neu Assay is an in vitro, diagnostic device intended for use in the quantitative determination of HER-2/neu in human serum. HER-2/neu values obtained may be used in the follow-up and monitoring of patients with metastatic breast cancer. HER-2/neu values should be used in conjunction with information available from clinical and other diagnostic procedures in the management of breast cancer. The clinical utility of the serum measurement of HER-2/neu as a prognostic indicator for early recurrence and in the management of patients on immunotherapy regimens has not been fully established.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K992228: Bayer Immuno 1 Her-2/Neu Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K992228

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026